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Abstract
Purpose: Nurse leaders driving strategic integration of genomics across 
nursing need tools and resources to evaluate their environment, guide 
strategies to address deficits, and benchmark progress. We describe the 
development and pilot testing of a self-assessment maturity matrix (MM) 
that enables users to benchmark the current state of nursing genomic 
competency and integration for their country or nursing group; guides the 
development of a strategic course for improvement and implementation; 
and assesses change over time.
Design: Mixed-methods participatory research and self-assessment.
Methods: During a 3-day workshop involving nursing experts in health 
care and genomics, a genomic integration MM grid was built by consensus 
using iterative participatory methods. Data were analyzed using descriptive 
techniques. This work built on an online survey involving the same par-
ticipants to identify the critical elements needed for “effective nursing 
which promotes health outcomes globally through genomics.”
Findings: Experts from 19 countries across six continents and seven or-
ganizations participated in item development. The Assessment of Strategic 
Integration of Genomics across Nursing (ASIGN) MM incorporates 55 out-
come-focused items serving as subscales for six critical success factors (CSFs): 
education and workforce; effective nursing practice; infrastructure and re-
sources; collaboration and communication; public/patient involvement; policy 
and leadership. Users select their current circumstances for each item against 
a 5-point ordinal scale (precontemplation to leading). Nurses representing 
17 countries undertook matrix pilot testing. Results demonstrate variation 
across CSFs, with many countries at the earliest stages of implementation.
Conclusions: The MM has the potential to guide the strategic integration 
of genomics across nursing and enables additional assessments within and 
between countries to be made.
Clinical Relevance: Nurse leadership and direction are essential to ac-
celerate integration of genomics across nursing practice and education. The 
MM helps nurse leaders to benchmark progress and guide strategic plan-
ning to build global genomic nursing capacity.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any 
medium, provided the original work is properly cited.
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Genomics is here to stay, bringing with it a new 
paradigm of health care through the emergence of 
precision medicine (Ginsburg & Phillips, 2018). The 
Global Genomics Nursing Alliance (G2NA, www.g2na.
org) recognizes the vital role that nurses can and 
do play in delivering genomic health care and the 
centrality of nursing leadership in enabling the inte-
gration of genomics into nursing care. The G2NA 
landscape analysis highlights wide variation in nurse 
preparation and involvement in genomics globally, 
with lack of visible nursing leadership being a bar-
rier to progress (Calzone et al., 2018a). Limited avail-
ability of supporting resources such as competency 
or curriculum guidelines, educational tools, and spe-
cialist genomics nursing societies (Calzone et al., 
2018b) compounds the challenge for nurse leaders 
who want to take a strategic approach to integrating 
genomics into nursing practice in their sphere of 
influence. To accelerate genomic integration in nurs-
ing education and practice, the G2NA sought to 
produce a flexible and accessible tool (maturity matrix 
[MM]) to guide global nurse leaders and facilitate 
benchmarking of the current state of nursing genomic 
competency and integration, and measure change 
over time. This article describes the development and 
pilot testing of the MM.
Background
Emergence of Precision Health Care
Ginsburg and Phillips (2018) outlined how, with 
costs of DNA sequencing declining, genomics and 
genome-based technologies are being used increasingly 
in diagnostic and predictive testing. New genomics 
approaches are forming the basis for reframing disease 
taxonomy, enabling more precise screening and earlier 
disease detection, with therapeutic options guided by 
individual genomic variations. With these advances, 
healthcare strategies are shifting from acute interven-
tion to genotype-guided risk management (including 
lifestyle choices), tailored health monitoring, and disease 
management. This facilitates therapeutic decisions to 
be targeted more precisely and is the basis of preci-
sion health care. Bilkey et al. (2019) presented examples 
of 12 applications of genetic testing from pre-conception 
to post-mortem molecular genetic testing, in clinical 
and wider healthcare settings. In addition, Bilkey et 
al. highlighted the challenges around the use of per-
sonal genomic data, including data sharing, informed 
consent, and dealing with unexpected findings. Clinically 
available genomic applications have immediate implica-
tions for nurses. These include having the capacity to 
provide patient/family education or informed consent; 
the need to understand clinical testing processes and 
possible test outcomes; to be aware of service path-
ways; and to appreciate ethical, legal, and socio-eco-
nomic aspects.
Genomics Implementation and Collaboration
Translational genomics activities span initial basic sci-
ence discoveries right through to population health 
impact studies (Schully & Khoury, 2014). They include 
development and evaluation of candidate applications 
and assessment of projects to implement and integrate 
genomics into routine clinical practice. Ginsburg and 
Phillips (2018) noted that translation of applications 
into clinical practice lags behind the pace of discovery. 
However, where patients’ genomic information is being 
used in clinical care, Manolio et al. (2013) found that 
such institutions tended to work in isolation rather 
than collaboratively. In their appraisal, Stark et al. (2019) 
summarized the increasing use of genomics in research 
and clinical practice and described the approaches and 
progress being made towards integration in four (high-
income) countries. Whilst the approaches in those 
countries may not be relevant to low- or middle-income 
countries, the benefits of sharing experiences and 
resources may increase the efficiency and effectiveness 
of implementation. Information on wider translation 
across global healthcare systems remains scarce.
Limited evidence exists for genomic implementation 
into practice and education considering varied condi-
tions and contexts (Calzone, Jenkins, Culp, & Badzek, 
2018; Jenkins & Calzone, 2014). Taylor et al. (2019) 
outlined a protocol for a study aimed at integrating 
genomics into clinical practice in 29 health systems 
in one country. The protocol aims to understand the 
complex adaptive systems needed for genomic practice 
integration, including clinical care effectiveness; policy 
and service provision; and individual level behavior 
change. Findings from this study will produce an 
evidenced-based toolkit to facilitate translating genomics 
into health care. It will expand existing strategies and 
resources for other health professionals and add to 
the nursing-specific clinical implementation toolkit from 
the Method for Introducing a New Competency: 
Genomics (MINC) study (Jenkins et al., 2015 https://
genom icsin tegra tion.net/). Given the scope and rapid 
expansion of evidence-based genomic clinical applica-
tions, these toolkits provide evidence-based strategies 
and resources for utilization in other countries to 
facilitate genomic translation to improve health out-
comes. As such, the global nursing collaborative G2NA 
is helping to compile and disseminate tools, facilitate 
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collaborative research, and contribute to best practices 
to accelerate the implementation of genomics into 
nursing practice.
Nursing and Genomics
Specialist genetics services, with their focus on the 
rarer inherited and chromosomal conditions, have long 
been the province of specially trained genetic nurses 
and counselors. However, all nurses care for individuals 
and families affected by inherited conditions as they 
encounter them in everyday practice. Precision medicine 
further broadens the focus across all health care as 
advances in understanding the genomic component of 
common diseases, targeted surveillance, and treatment 
selection have implications for all specialties and health-
care providers. Nurses, as the largest global health 
professional workforce, who spend the most time with 
patients in both acute and community settings, and 
deliver direct care as well as patient family education, 
are essential for genomic translation into clinical prac-
tice. There have been significant and sustained efforts 
internationally to articulate roles and genomic compe-
tencies that nurses in any specialty and level of aca-
demic preparation should be able to demonstrate when 
implementing genomics into nursing practice. Genomic 
nursing competency contributes to achieving the poten-
tial of genomic science and technologies, to meet the 
needs of patients or families, and to improve healthcare 
quality, efficacy, and safety. However, evidence of vari-
ability in capacity, capability, and confidence in genomics 
has been well documented even in countries with 
sustained genomic nursing competency efforts (Calzone 
et al., 2018a; Jenkins, 2019).
Kirk, Calzone, Arimori, and Tonkin (2011) explored 
perspectives on nursing and integration of genomics 
across 10 countries. They found that nursing leader-
ship and engagement of senior nurses within govern-
ment and nursing regulation was fundamental for 
nurses to play a part in delivering genomic health 
care. However, nurse leaders faced resource constraints 
to support change initiatives (Jenkins, 2019). Nursing 
leaders having access to established resources will reduce 
the duplication of effort, facilitate learning from each 
other, and enable collaborations for evidence genera-
tion of best practices. In turn, this will help accelerate 
genomic nursing integration.
The Maturity Matrix
An MM is used to assess the progress of development 
of an organization or unit over time, identify develop-
ment needs, and stimulate quality improvement efforts 
(Buch, Edwards, & Eriksson, 2009). The MM approach 
was originally developed within health service settings 
by Elwyn et al. (2004) to assess practice developments 
in primary care settings and to promote communication 
and learning. They found it provided insight into improve-
ment needs and prioritization, with high face validity. 
Subsequent studies adapted MMs for use in several 
European countries, such as the International Family 
Practice Maturity Matrix (Elwyn et al., 2010). A version 
developed for dentistry (the Maturity Matrix Dentistry) 
includes 12 domains (Barnes et al., 2012). In the United 
Kingdom, Cardiac Genetics Nurses used an MM to track 
progress in the development of inherited cardiac condi-
tions services. Its five domains provided a comprehensive 
assessment framework (Kirk et al., 2014).
An MM consists of a series of concepts or domains, 
displayed as a grid that incorporates the sub-components 
(termed key enablers) of each domain. Each row shows 
a criterion, or indicator, of a key enabler, with the expected 
development stage of that indicator shown for a given 
stage of maturity (Table S1). The maturity stages are 
incremental and assume that the outcomes of the previ-
ous stages have been met. While maturity matrices have 
a common structure and are based on self-assessment, 
the content is flexible and adaptable and can be devel-
oped specifically for the needs of a particular service, 
group, or organization (Maier, Moultrie, & Clarkson, 2012). 
MMs can operate at micro (e.g., local teams), meso (e.g., 
healthcare organization), and macro (e.g., national/inter-
national) levels. At each level, the MM provides a frame-
work for assessment and advancement of capability and 
capacity. Importantly, the MM also provides a common 
measurement system for healthcare systems delivering 
care regardless of country-specific factors.
Aims
Nurses worldwide lack confidence and competence 
in teaching genomics and using genomics in practice 
(Anderson et al., 2015). Resources are limited, and 
progress in genomic implementation in education and 
practice varies widely (Calzone et al., 2018a, 2018b). 
To address these deficits, strategic approaches are needed 
to guide change initiatives in genomics and measure 
outcomes. Our primary aim was to develop and pilot 
test a new MM for nursing that assesses the status 
of genomics integration within a nursing group (e.g., 
country, hospital, academic program).
Methods
Creating the MM was predicated on three assump-
tions. The framework needs to (a) be broad and 
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flexible to accommodate different socio-economic, politi-
cal, and cultural factors, and the dynamic nature of 
both genomics and nursing; (b) consider the broader 
nursing context; and (c) have evaluation outcomes 
that are wide ranging to accommodate different stages 
of maturity. The Faculty of Life Sciences and Education 
Ethics Committee, University of South Wales, reviewed 
and approved this project (Ref 2017ETMK1201).
Participants
A purposive sample of experts with senior nursing 
leadership roles and expertise in health care, nursing, 
education, policy, and genomics, and a representative 
of a national genetic conditions advocacy organization 
attended a 3-day workshop to discuss the formation 
of G2NA. Expertise in genomics was not essential. 
For the purpose of the event, individuals primarily 
represented either their country or an organization. 
All participants had the opportunity to contribute to 
Phases 1 and 2 of MM development. Country repre-
sentatives pilot tested the MM. Countries with more 
than one person in attendance submitted a single 
response.
Procedures
MM development took place over three broad phases 
(Figure S1).
Phase 1: Selection and refinement of critical 
success factors (CSFs). To identify potential key 
themes for constructing the MM, we invited G2NA 
workshop participants through Online Surveys (www.
onlin esurv eys.ac.uk, formerly BOS) to propose a 
maximum of six responses to the following question: 
“What are the core essential elements for effective 
nursing which promotes health outcomes globally 
through genomics?” Items were coded independently by 
two authors and categorized through discussion. 
Consensus on the final themes (CSFs) was reached with 
participants through discussion and real-time electronic 
voting at the workshop.
Phase 2: Development of MM key enablers and 
incremental scales. At the workshop we used an 
iterative, consensus-building approach (Kirk et al., 2014) 
that drew on Liberating Structures methods (Lipmanowicz 
& McCandless 2014) to establish the key enablers and 
incremental scales. Participants worked in mixed small 
groups on one CSF at a time to identify the underpinning 
key enablers and the indicators that could be used to 
illustrate the achievement of each key enabler. Participants 
formulated what progress against each indicator might be 
expected over time and considered what measures could 
be used as evidence of progress. All information was 
captured on worksheets. Iteratively, groups rotated 
through each CSF, reviewing prior group comments. One 
workshop organizer acted as a facilitator for each CSF 
remaining with the worksheet, providing clarification and 
context to comments of prior groups. In the final round, 
the original group was able to review all comments and 
revisions made by subsequent groups to its initial outline.
Phase 3: Refinement and Feasibility Pilot. The 
key enablers, indicators, progress descriptions, and 
measures generated by participants were reviewed, 
synthesized, and refined post-workshop by the organizers 
to create the MM now entitled Assessment of Strategic 
Integration of Genomics across Nursing (ASIGN). 
Participants were then invited to pilot test ASIGN online 
by self-assessing for each indicator the current situation of 
their country, to the best of their knowledge and in 
collaboration with others as appropriate. Two paper-based 
versions of ASIGN were also created. The ASIGN Self-
Assessment Document is the same as the online version 
and contained blank cells for users to mark the assessed 
stage of change. Free text boxes captured comments 
about measures used, with supporting evidence and 
further general comments on the likely pace of progress 
for each CSF. The ASIGN Reference Document (Figure 
S2) is for information only, providing explanation about 
Table 1. Stages of Maturity and Corresponding Definitions
Stage of maturity Definition
Pre-contemplation There is little or no evidence of the indicator from any appropriate, identified measure that has been selected by the 
assessor.
Awareness and planning There is some evidence of awareness of the need to address the indicator and planning is underway to do so, although 
there may be little or no evidence of the indicator being in place from any appropriate identified measure.
Active commitment Plans are being implemented and there is some evidence that progress is being made.
Embedded Substantial progress has been made and the indicator is demonstrably established across most practice fields.
Leading The indicator is embedded as the norm and the unit being assessed champions good practice and leadership in 
engaging others in demonstrating the indicator and promoting continuous improvement.
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completion, with example measures that could be used 
for each key enabler and definitions of the five stages of 
maturity used (Table 1). Timescales were not defined for 
movement through stages 1 to 5, since these are 
dependent on wider local and national contexts. We also 
acknowledged that there is not necessarily an equal 
distance between the stages of maturity. Feedback was 
requested on whether ASIGN represented the discussion 
and content generated at the workshop as well as 
participants’ experience completing the country 
assessment, including whether the maturity progression 
followed a logical path, how confident they felt in their 
assessments, and the time taken to complete ASIGN.
Analysis
Data were exported into Excel and frequencies cal-
culated for the number of countries at each stage of 
maturity for individual key enablers. The same approach 
was used to calculate frequencies on the participant 
feedback on experience of utilizing and completing 
ASIGN. Stages of maturity were coded 0 to 4 (0 = 
pre-contemplation and 4 = leading). The total scores for 
each CSF for individual countries were calculated, as 
were the percentages of the maximum scores for each 
CSF. Data for all countries were then combined to 
calculate an overall distribution for each CSF. Cluster 
analysis to group the CSFs according to similarity in 
assessment was performed using the complete linkage 
method (Euclidean distance), utilizing each country’s 
mean score.
Results
Participants and ASIGN Development
A total of 30 individuals (including the 6 workshop 
organizers) with a range of professional backgrounds, 
Table 2. Countries or Organizations Participating in ASIGN Development or Pilot Testing
Country or 
organization
Number of 
participants
Educator (E), clinician (C), 
organization leader (OL)
Genomic expertise
Yes/No
Phase 1 CSF 
survey Yes/No
ASIGN development 
participation
Yes/No
Pilot test 
participation
Yes/No
Australia 1 E Yes No No Yes
Brazil 1 E, C Yes Yes Yes Yes
Canada 1 E Yes Yes Yes Yes
Columbia 1 E No Yes Yes Yes
Germany 1 E No Yes Yes Yes
Hong Kong 1 E Yes Yes Yes Yes
Israel 1 E Yes No Yes Yes
Japan 1 E Yes Yes Yes Yes
Mexico 1 E Yes No Yes Yes
Netherlands 1 C Yes No Yes Yes
Norway 1 C Yes No Yes No
Nigeria 1 E No No No Yes
Pakistan 1 C Yes Yes Yes Yes
South Africa 1 E No No Yes No
Switzerland 1 E Yes Yes Yes Yes
Taiwan 1 C Yes Yes Yes Yes
Turkey 1 E Yes Yes Yes Yes
United Kingdom 5 E (n = 2) and C (n = 3) Yes Yes (n = 2) Yes Yes
United States 2 E, C Yes Yes (n = 1) Yes Yes
EBMG 1a OL, C Yes No Yes No
GAUK 1 OL Yes No Yes No
HEE 2 OL Yes No Yes No
ICN 1 OL Yes No Yes No
ISONG 1 OL, C Yes Yes Yes No
STTI 1 OL, E Yes Yes Yes No
NHGRI 1b C Yes No Yes No
Note. ASIGN = Assessment of Strategic Integration of Genomics across Nursing; EBMG = European Board of Medical Genetics; GAUK = Genetic 
Alliance UK; HEE = Health Education England; ICN = International Council for Nurses; ISONG = International Society of Nurses in Genetics; NHGRI = 
National Human Genome Research Institute (U.S.A.); STTI = Sigma Theta Tau International.
aAlso represented the United Kingdom.
bAlso represented the United States.
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most with some genomic expertise, representing 19 
countries across six continents and seven organizations 
were involved in the development or pilot testing of 
ASIGN (Table 2). Countries and organizations were 
each represented by one person, with the exception 
of the United Kingdom and the United States (work-
shop organizers), and Health Education England. Fifteen 
Phase 1 survey respondents generated 84 core elements 
of genomic health care, which was reduced to 63 
after removal of duplicates. Thematic analysis resulted 
in seven categories. Participant discussion and voting 
(not including the organizers) resulted in six distinct 
CSFs (A–F) necessary for delivering effective nursing 
care that promotes improved health outcomes through 
genomics (Table 3). Phase 2 group work and post-
workshop refinement produced a total of 19 key ena-
blers and 55 indicators across the six CSFs (see Table 
3). Full details of the CSFs, key enablers, and indicators 
that make up ASIGN are provided in Table S2.
ASIGN Pilot Testing
Of 19 eligible country representatives, 17 completed 
the pilot. One country representative forwarded the 
pilot to a graduate student who also completed the 
assessment; the student responses were excluded from 
the analysis. The U.S. pilot was completed jointly by 
both representatives. Only one U.K. participant com-
pleted that country’s assessment.
Country assessments (percentage of maximum score) 
for each CSF (Figure 1) illustrate the variability and 
distribution within and between CSFs. Cluster analysis 
(Figure 2) shows similarity in responses from countries 
to CSFs A and F, for which respondents located most 
indicators at the two earliest stages of maturity (“pre-
contemplation” and “awareness and planning”). Figure 
2 also illustrates the dissimilarity of responses to A 
and F compared to the other four CSFs, where indi-
cators have a greater spread across all stages of 
maturity.
The number of countries at each stage of maturity 
for the 19 key enablers is illustrated in Figure S3. In 
summary, for CSF A (enhanced education and work-
force development), most countries self-assessed as 
being at stage 1 (precontemplation) or 2 (awareness 
and planning). Stage 5 (leading) was selected by only 
one respondent, for two of the four indictors within 
the key enabler “culture of positive attitude towards 
nursing and genomics.” CSF B (effective nursing prac-
tice) had a greater spread across the maturity stages 
for the key enablers “evidence-informed practice” and 
“ethical and safe practice,” with the indicator “policies 
regarding the confidentiality and use of genomic 
information” (B4-2; see Table S2) at stages 4 (embed-
ded) or 5 in nine countries. However, only two coun-
tries assessed both indicators for “clearly defined patient 
outcomes” as being at stage 3 (active commitment) 
or greater. The picture for CSF C (infrastructure and 
resources that support incorporation of genomics in 
practice) is more variable. A range of maturity for 
the indicators of “service capacity” was observed, with 
five countries assessing all four indicators at stages 4 
or 5. In contrast, most countries reported being at 
stage 1 for the three indicators of “human resources 
that support nursing career potential.” Within CSF D 
(inter-professional collaboration and communication), 
countries appear to be at a range of maturity for 
“strong working relationships” and “effective commu-
nication,” with evidence of practice that is embedded 
or leading. However, the indicators for “collaboration 
across boundaries to share genomics knowledge, exper-
tise, and resources” are still at stages 1 or 2 for most 
countries. Responses to CSF E (family and community 
focused care) indicate some movement towards more 
mature stages of practice, with some evidence of at 
least embedded activity for all indicators. CSF F (health-
care transformed through policy and leadership) is 
composed of nine indicators, with most assessments 
at stages 1 or 2. For five nursing leadership indicators 
(F1.3, F2.1, F2.2, F3.1, and F3.3; see Table S2 for 
details) there was no progress in any country beyond 
active commitment (stage 3).
All respondents indicated that the matrix followed 
a logical progression across each indicator. All of those 
who attended the workshop responded that ASIGN 
represented the discussions held. Some variation in 
self-confidence when completing the assessment was 
noted, with 11 of 17 (65%) being either very 
Table 3. The Number of Key Enablers and Indicators Across the Six 
Critical Success Factors (A–F) of ASIGN
Critical success factor Key enablers Indicators
A. Enhanced education and workforce 
development
3 9
B. Effective nursing practice 4 12
C. Infrastructure and resources that 
support incorporation of genomics in 
practice
3 11
D. Interprofessional collaboration and 
communication
3 7
E. Family- and community-focused care 3 7
F. Health care transformed through policy 
and leadership
3 9
Total 19 55
Note. ASIGN = Assessment of Strategic Integration of Genomics across 
Nursing.
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confident or confident of accuracy and consistency 
across their country. However, three people raised 
concerns about potential regional differences, with one 
commenting, “Since the wealth gap between urban 
and rural areas is very wide, it will be very challeng-
ing for the MM to benchmark progress in such a 
heterogeneous [country] serving different populations.” 
Most did not or could not provide estimates of the 
timescales in which they anticipated progress for each 
of the CSFs, although one respondent predicted at 
least a 5- to 10-year timescale in their country before 
significant progress could be made in any of the CSFs.
Comments about completing the assessment were 
generally positive, but for some the exercise was more 
time consuming, depending on level of wider context, 
access to corroborating evidence, and first language. 
Whilst some had found the supporting documents use-
ful, one commented that it “was a bit long and 
cumbersome.”
Discussion
ASIGN provides a systematic approach to managing 
the strategic integration of genomics across nursing 
and is the first MM developed for this purpose. It 
fosters comprehensive evaluation from the outset, 
informs revision of current strategies or development 
of new ones, and provides evidence to support target-
ing of resources. Ongoing self-assessment and evalu-
ation will help make the nursing role more visible 
and promote a greater appreciation of the nursing 
contribution to genomic healthcare.
The essential elements that need to be in place for 
nurses to be able to deliver effective care that integrates 
genomics into standard practice are explicit within ASIGN. 
The tool provides the basic framework to guide further 
development in genomics, including guiding academic 
and continuing education. By using the matrix as a 
framework for assessment, groups, organizations, or 
countries can use ASIGN to benchmark themselves at 
Figure 1. Number of countries and percentage of the total maximum score achieved for each critical success factor in Assessment of Strategic 
Integration of Genomics across Nursing (ASIGN). A = enhanced education and workforce development; B = effective nursing practice; C = infrastructure 
and resources that support incorporation of genomics in practice; D = interprofessional collaboration and communication; E = family- and community-
focused care; F = health care transformed through policy and leadership.
0
2
4
6
8
10
12
0-20% 20-40% 40-60% 60-80% 80-100%
A B C D E F
Figure 2. Cluster analysis of the critical success factors (Euclidean 
distance). A = enhanced education and workforce development; B = 
effective nursing practice; C = infrastructure and resources that support 
incorporation of genomics in practice; D = interprofessional collaboration 
and communication; E = family- and community-focused care; F = health 
care transformed through policy and leadership.
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a starting point to inform a plan for progress. The tool 
is nimble, as users can be a country or region within 
a country, or an organization such as a hospital, profes-
sional body, or government. Focusing on outcomes, users 
of ASIGN can capture both the current status and change 
over time. Comparisons between indicators and stage 
of maturity (i.e., high vs. low maturity) can help users 
identify areas where work needs to be focused. Individuals 
can identify the most appropriate measures (evidence) 
for each indicator, thus offering some flexibility, in rec-
ognition that there will be wide variations in resources, 
infrastructure, and service provision across countries, 
regions, or organizations. Acknowledging the variations 
between countries (Calzone, Jenkins, et al., 2018) influ-
enced by political, fiscal, and environmental aspects 
beyond their control, data on individual countries are 
not presented and comparisons between countries have 
not been made.
This pilot study data provide insight into the current 
status and role of nurses in relation to genomics. One 
respondent commented that it would be 5 to 10 years 
before genomics becomes a nursing priority in their 
(European) country. The scale and nature of change 
needed to promote and achieve genomics integration 
is substantial, and ASIGN reflects this in requiring 
appraisal across six domains, with 19 key enablers 
and a total of 55 indicators. To facilitate change, nurse 
leaders need to consider not just the content of ASIGN, 
but also the wider context for change and the change 
process itself. For this reason, ASIGN has been set 
into a wider facilitative framework (roadmap) by G2NA 
to provide practical guidance (Tonkin et al., 2020).
Limitations
ASIGN incorporates multiple concept domains, key 
enablers, and indicators that are not mutually exclusive, 
with inherent overlap. To make the MM feasible for 
completion, similar related items associated with the 
same indicator were grouped together. For example, 
C1.4 (bioinformatics and IT support for variation inter-
pretation, data storage, retrieval, and reporting are in 
place; see Table S2) grouped four closely related items: 
interpretation, storage, retrieval, and reporting. The intent 
for this indicator and others like it is to have an over-
arching assessment on the state of maturity, which 
considers each item to render an overall determination 
for the indicator. We recognize that a group performing 
an assessment may identify different stages of maturity 
for individual items, and this could cause confusion 
on how to establish the overall stage of maturity. 
However, we had to balance the need to retain enough 
detail (to guide development in an area) with 
achieving an MM that was realistic in size and scope 
for usability. Pilot testing did not reveal this to be a 
significant problem, with just one country identifying 
the issue. As greater maturity is achieved for an item, 
this issue could be a greater concern for users.
The next steps are to conduct additional testing for 
further refinement. At the Nursing, Genomics, and 
Healthcare international conference taking place in July 
2021, completion of ASIGN by a larger group of par-
ticipants is planned. These data will be used to perform 
factor analysis, which is expected to help in coalescing 
or removing items thereby further refining ASIGN. 
Additionally, a subset of volunteers will be recruited 
to participate in a talk aloud session with facilitators 
that will audio record responses to targeted usability 
and language clarity questions. Both sets of participants 
will be asked to complete ASIGN a second time in a 
short interval following the conference to do prelimi-
nary test-retest reliability assessment. These assessments 
will inform revisions.
Conclusions
ASIGN is the first MM designed and piloted to assess 
the integration of genomics into nursing. ASIGN is 
based on expected outcomes, predefined by key stake-
holders that consisted of global nursing leaders from 
practice, education, and research, with and without 
genomic expertise. The matrix is outcome focused, 
capturing both stage of maturity and continuity, and 
enables assessment of changes over time. ASIGN is 
amenable for use in a variety of environments, includ-
ing clinical, educational (nursing school), and profes-
sional (nursing organization), and at different scales, 
from hospital department to countrywide assessments. 
ASIGN helps answer the question “What does effective 
nursing which promotes health outcomes globally 
through genomics look like?” Coupled with the com-
panion roadmap (Tonkin et al., 2020), ASIGN can be 
used as a reference point to inform further strategic 
genomic implementation development and measure 
change over time.
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